FIELD: medicine, ophthalmology. SUBSTANCE: method deals with treating dystrophic diseases of retina and an optic nerve. Firstly, one should resect conjunctiva and Tenon's membrane to form a pouch in Tenon's space, then a purse-string suture is applied and a peptide bioregulator is introduced into Tenon's space at 1000-10000 Da molecular weight isolated out of retina or bovine brain cortex, correspondingly, then a purse-string suture is tightened up. The method provides prolonged supply of preparation from Tenon's space into area of pathological process. EFFECT: higher efficiency of therapy. 2 cl, 6 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
| METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
| METHOD FOR TREATING TUBERCULOUS UVEITES | 2006 |
|
RU2318534C2 |
| AGENT INHIBITING ANGIOGENESIS IN VISUAL ORGAN DISEASE | 2001 |
|
RU2177801C1 |
| METHOD FOR TREATING THE CASES OF SCLEROTIC RETINAL MACULODYSTROPHY | 2003 |
|
RU2235526C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY IN INFANTS | 2011 |
|
RU2458702C1 |
| METHOD FOR TREATMENT OF TUBERCULOSIS UVEITIS | 2004 |
|
RU2290191C2 |
| METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
| METHOD OF THE TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2022 |
|
RU2801496C1 |
